U.S. investors, Big Pharma race to find new medicines in China
U.S. investors and large pharmaceutical companies are increasingly doing deals in China as the country’s biopharma sector ...
Stifel Nicolaus Sticks to Its Buy Rating for Casella Waste (CWST)
In a report released today, Brian Butler from Stifel Nicolaus maintained a Buy rating on Casella Waste (CWST – Research Report), with a price ...
Bernstein cuts Kraft Heinz stock target to $34, keeps Outperform
Bernstein analysts led by Alexia Howard revised the price target for Kraft Heinz Company (NASDAQ:KHC) shares, reducing it to $34 from the previous $40, while maintaining an Outperform rating.